Engaged Capital LLC
The positions Engaged Capital LLC reported on its Form 13F for Q2 2026, the quarter ending 30 Jun 2026, filed on 14 Aug 2026. Every figure below is the filing’s own: US-listed long equity, valued at the quarter end, with the change measured against the same manager’s previous filing.
Opened this quarter
A new position is the clearest thing a filing says. Somebody argued for it recently, and it is the easiest question to be ready for.
- Freshpet Inc (FRPT)$29m · 8.8%
- Evolent Health Inc (EVH)$4.2m · 1.3%
Sold out of this quarter
Exits are valued at what the position was worth in the previous filing, because by this one it is gone.
Nothing was sold out of. Every name held last quarter is still on the filing.
Every reported position, Q2 2026
10 positions, sorted by weight
| Position | Weight ↑ | Value | Shares | Change on the quarter | Action |
|---|---|---|---|---|---|
Evolent Health Inc (EVH) NOTE 3.500%12/0 · CUSIP 30050BAH4 | 1.3% | $4.2m | 5,500,000 | No earlier filing | New |
BRC Inc COM CL A · CUSIP 05601U105 | 4.7% | $16m | 13,935,560 | +$4.7m 0 shares | Held |
Portillos Inc COM CL A · CUSIP 73642K106 | 5.0% | $16m | 3,442,990 | -$1.9m 0 shares | Held |
Blackline Inc (BL) COM · CUSIP 09239B109 | 7.1% | $23m | 827,619 | -$27m -540,000 shares | Trimmed |
Cognex Corp (CGNX) COM · CUSIP 192422103 | 7.5% | $25m | 339,000 | +$800k -145,000 shares | Trimmed |
Freshpet Inc (FRPT) COM · CUSIP 358039105 | 8.8% | $29m | 484,741 | No earlier filing | New |
Evolent Health Inc (EVH) CL A · CUSIP 30050B101 | 9.2% | $30m | 5,563,912 | +$18m 0 shares | Held |
Gxo Logistics Incorporated (GXO) COMMON STOCK · CUSIP 36262G101 | 15% | $50m | 984,769 | +$7.3m +163,000 shares | Added |
Yeti HLDGS Inc COM · CUSIP 98585X104 | 18% | $59m | 1,194,095 | -$6.1m -590,000 shares | Trimmed |
V F Corp (VFC) COM · CUSIP 918204108 | 23% | $75m | 4,521,894 | -$4.1m -157,095 shares | Trimmed |
Every filing on file
| Quarter | Period end | Filed | Book | Positions | Top 10 | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | 30 Jun 2026 | 14 Aug 2026 | $327m | 10 | 100% | 13F-HR |
| Q1 2026 | 31 Mar 2026 | 15 May 2026 | $303m | 8 | 100% | 13F-HR |
| Q4 2025 | 31 Dec 2025 | 17 Feb 2026 | $392m | 9 | 100% | 13F-HR |
| Q3 2025 | 30 Sept 2025 | 14 Nov 2025 | $408m | 9 | 100% | 13F-HR |
| Q2 2025 | 30 Jun 2025 | 14 Aug 2025 | $358m | 7 | 100% | 13F-HR |
| Q1 2025 | 31 Mar 2025 | 15 May 2025 | $392m | 9 | 100% | 13F-HR |
| Q4 2024 | 31 Dec 2024 | 14 Feb 2025 | $486m | 8 | 100% | 13F-HR |
| Q3 2024 | 30 Sept 2024 | 14 Nov 2024 | $617m | 9 | 100% | 13F-HR |
Taking this into the room
Pick one name from the top of the book and one from the new positions, and know both properly: what the company earns, what it is priced at, and what has to be true for the position to work. That is a conversation. Reciting the whole table is not, and the interviewer wrote it.
A position sold out of is worth as much preparation as one opened. Ask what changed rather than asserting the fund was wrong, and be ready for the answer that the thesis played out and the money went somewhere better.
What this filing leaves out
A 13F covers US-listed long equity at one moment in time. Shorts, bonds, cash, private positions and non-US listings never appear, and options are reported in a form that will mislead you if you read them as a position. A long/short manager showing $8bn here may run a book several times that size.
The lag matters too. Positions are as at the quarter end and the filing arrives up to forty-five days later, so what you are reading is at least six weeks old and possibly four months. Phrase it as what the filing showed, not what the fund holds today.
Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More